Parexel Execs On How To Adapt Clinical Studies Amid The Pandemic
Decentralized, Remote Approaches Adopted
Parexel executives tell Scrip about the company’s efforts in tandem with sponsors to navigate the challenging clinical research environment amid COVID-19. A renewed interest for decentralized trials or hybrid approaches and the use of remote monitoring and telehealth visits to keep studies moving are some of the key initiatives.
